Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

13. Mai 2026 09:30 ET | Quelle: SNS Insider pvt ltd

Spear Phishing Market Size to Reach USD 6.36 Billion by 2035, Fueled by Rising Sophistication of Cyberattacks and Remote Work Adoption | Research by SNS Insider

Austin, May 13, 2026 (GLOBE NEWSWIRE) -- The Spear Phishing Market was valued at USD 2.01 Billion in 2025 and is expected to reach USD 6.36 Billion by 2035, growing at a CAGR of 12.23% over the...
13. Mai 2026 09:00 ET | Quelle: Biofrontera Inc.

Biofrontera Launches Second Annual “Hats On” Campaign to Raise Awareness of Actinic Keratosis

The second annual #HatsonforAK Campaign runs May 18–24, 2026, culminating on Global Actinic Keratosis (AK) Awareness DayThis social media–driven initiative invites people to wear a hat, share a photo,...
13. Mai 2026 08:30 ET | Quelle: BioMedWire

Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities

AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Obesity and type 2 diabetes mellitus (T2DM) rank among the most urgent and costly healthcare problems facing the world...
13. Mai 2026 08:30 ET | Quelle: BioMedWire

CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research

AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Among the most guarded structures in human biology, the brain is also one of the hardest to treat. The blood-brain...
13. Mai 2026 07:16 ET | Quelle: SNS Insider pvt ltd

Personalized Retail Nutrition and Wellness Market Set to Rebound with 15.50% CAGR, Reaching USD 19.34 Billion by 2035 – SNS Insider

Austin, United States, May 13, 2026 (GLOBE NEWSWIRE) -- “As per the SNS Insider, the Personalized Retail Nutrition and Wellness Market was valued at USD 4.58 billion in 2025 and is projected to...
13. Mai 2026 07:00 ET | Quelle: Atea Pharmaceuticals, Inc.

Atea Pharmaceuticals to Present Three Abstracts at EASL 2026 Congress Highlighting Progress Across Viral Hepatitis Pipeline

BOSTON, May 13, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral...
13. Mai 2026 07:00 ET | Quelle: Avalo Therapeutics

Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates

Achieved positive topline results in Phase 2 LOTUS trial of abdakibart in moderate to severe hidradenitis suppurativa (HS) and plan to advance into a registrational phase 3 programCompleted public...
13. Mai 2026 06:02 ET | Quelle: Research and Markets

Cognitive Assessment & Training for the Global Alzheimer's Disease Market 2026-2032 - AI-Enhanced Alzheimer's Care Shifts Focus to Continuous Monitoring and Biomarker-Integration

Dublin, May 13, 2026 (GLOBE NEWSWIRE) -- The "Cognitive Assessment & Training for Alzheimer's Disease Market by Offering Type, Delivery Mode, Technology Platform, Supervision Level, Disease...
13. Mai 2026 06:00 ET | Quelle: Research and Markets

Digital Biomarkers Market Trends and Growth Outlook 2026-2031: Emerging Applications in Neurological and Mental Health Monitoring Present Lucrative Opportunities

Dublin, May 13, 2026 (GLOBE NEWSWIRE) -- The "Digital Biomarkers Market by Type, Therapy, Application, End User - Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering.The...
12. Mai 2026 17:03 ET | Quelle: TheRas, Inc. (d/b/a BBOT)

BBOT Reports First Quarter 2026 Financial Results and Update on Corporate Progress

Announced encouraging preliminary safety and efficacy data across all three RAS-pathway inhibitor programsAnnounced publication in Cancer Discovery highlighting preclinical data demonstrating...

Nächste Seite